Comparison of advanced glycation endproducts on haemoglobin (Hb-AGE) and haemoglobin A(1c) for the assessment of diabetic control

Clinica Chimica Acta

Volumn 277, Issue 2, 1998, Pages 159-170

  Turk, Z ^a   Mesic R ^a   Benko, B ^b  

^a University of Zagreb   (Croatia)

^b INSTITUTE OF IMMUNOLOGY   (Croatia)

Author keywords

Advanced glycation endproducts; Diabetes mellitus; Glycated haemoglobin

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ANTIBODY; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN; HEMOGLOBIN A1C;

ADULT; ARTICLE; CHROMATOGRAPHY; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DIABETIC RETINOPATHY; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE; FEMALE; GLUCOSE BLOOD LEVEL; GLYCATION; HUMAN; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADULT; BLOOD GLUCOSE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GLYCOSYLATION END PRODUCTS, ADVANCED; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED;

EID: 0031783569     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-8981(98)00128-4     Document Type: Article

References (17)

1. Brownlee M, Cerami A, Vlassara H. Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. New Engl J Med 1988;318:1315-21.
2. Njoroge FG, Monnier VM. The chemistry of the Maillard reaction under physiological conditions: a review. In: Baynes JW, Monnier VM, editors. The Maillard Reaction and Aging, Diabetes and Nutrition. New York: AR Liss, 1989:85-109.
3. Kennedy L. Glycation of haemoglobin and serum proteins. In: Alberti KGMM, DeFronzo RA, Keen H, Zimmet P, editors. International Textbook of Diabetes Mellitus. Chichester: John Wiley, 1992:985-1007.
4. Vlassara H, Bucala R, Striker L. Pathogenic effects of advanced glycosylation: biochemical, biologic, and clinical implications for diabetes and aging. Lab Invest 1994;70:138-51.
5. Thornalley PJ. Advanced glycation and the development of diabetic complications. Unifying the involvement of glucose, methylglyoxal and oxidative stress. Endocrinol Metab 1996;3:149-66.
6. Hammes HP, Brownlee M. Advanced glycation end products and pathogenesis of diabetic complications. In: LeRoith D, Taylor SI, Olevsky JM, editors. Diabetes mellitus. Philadelphia: Lippincott-Raven Publishers, 1996:810-15.
7. Horiuchi S, Araki N, Morino Y. Immunochemical approach to characterize advanced glycation end products of Maillard reaction. J Biol Chem 1991;266:7329-32.
8. Makita Z, Vlassara H, Cerami A, Bucala R. Immunochemical detection of advanced glycation end products in vivo. J Biol Chem 1992;267:5133-8.
9. Makita Z, Vlassara H, Rayfield E, et al. Haemoglobin-AGE: a circulating marker of advanced glycosylation. Science 1992;258:651-3.
10. Hodge JE, Rist CE. The Amadori rearrangement under new conditions and its significance for nonenzymatic browning reactions. J Am Chem Soc 1953;75:316-22.
11. Jeppsson JO, Jerntorp P, Sundkvist G, Englund H, Nylund V Measurement of haemoglobin A1c by a new liquid-chromatographic assay: methodology, clinical utility, and relation to glucose tolerance evaluated. Clin Chem 1986;32:1867-72.
12. Lowry O, Rosenbrough NJ, Farr AL, Randale RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951;193:265-75.
13. Makita Z, Nakayama H, Taneda S, et al. Radioimmunoassay for the determination of glycated haemoglobin. Diabetologia 1991;34:40-5.
14. Nakayama H, Taneda S, Kuwajima S, et al. Production and characterization of antibodies to advanced glycation products on proteins. Biochem Biophys Res Commun 1989;162:740-4.
15. Dolhofer-Bliesener R, Lechner B, Gerbitz KD. Possible significance of advanced glycation end products in serum in end-stage renal disease and in late complications of diabetes. Eur J Clin Chem Clin Biochem 1996;34:355-61.
16. Wolffenbuttel BHR, Giordano D, Founds HW, Bucala R. Long-term assessment of glucose control by haemoglobin-AGE measurement. Lancet 1996;347:513-5.
17. Vlassara H. Recent progress in advanced glycation end products and diabetic complications. Diabetes 1997;46(Suppl 2):S19-25.